183 related articles for article (PubMed ID: 17172824)
1. Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole.
Shin KH; Diaz-Gonzalez JA; Russell J; Chen Q; Burgman P; Li XF; Ling CC
Cancer Biol Ther; 2007 Jan; 6(1):70-5. PubMed ID: 17172824
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of changes in tumor hypoxia.
Russell J; Carlin S; Burke SA; Wen B; Yang KM; Ling CC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1177-86. PubMed ID: 19251089
[TBL] [Abstract][Full Text] [Related]
3. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines.
Troost EG; Bussink J; Kaanders JH; van Eerd J; Peters JP; Rijken PF; Boerman OC; van der Kogel AJ
Radiother Oncol; 2005 Aug; 76(2):194-9. PubMed ID: 16024110
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
6. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
[TBL] [Abstract][Full Text] [Related]
8. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
[TBL] [Abstract][Full Text] [Related]
9. Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.
Li XF; Sun X; Ma Y; Suehiro M; Zhang M; Russell J; Humm JL; Ling CC; O'Donoghue JA
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):339-48. PubMed ID: 19921184
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.
He F; Deng X; Wen B; Liu Y; Sun X; Xing L; Minami A; Huang Y; Chen Q; Zanzonico PB; Ling CC; Li GC
Cancer Res; 2008 Oct; 68(20):8597-606. PubMed ID: 18922936
[TBL] [Abstract][Full Text] [Related]
12. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.
Bao B; Groves K; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Rajopadhye M; Peterson JD
PLoS One; 2012; 7(11):e50860. PubMed ID: 23226406
[TBL] [Abstract][Full Text] [Related]
14. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.
Hoskin PJ; Sibtain A; Daley FM; Wilson GD
Br J Cancer; 2003 Oct; 89(7):1290-7. PubMed ID: 14520462
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
Olive PL; Aquino-Parsons C; MacPhail SH; Liao SY; Raleigh JA; Lerman MI; Stanbridge EJ
Cancer Res; 2001 Dec; 61(24):8924-9. PubMed ID: 11751418
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride.
Westbury CB; Pearson A; Nerurkar A; Reis-Filho JS; Steele D; Peckitt C; Sharp G; Yarnold JR
Br J Radiol; 2007 Nov; 80(959):934-8. PubMed ID: 17908818
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
